Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1978-04-20
1980-10-07
Padgett, Benjamin R.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
260112R, 260122, 424 15, 424 9, A61K 2900, A61K 4300, C07G 700
Patent
active
042268460
ABSTRACT:
Microaggregates of a complex of (1) albumin, particularly human serum albumin and (2) a metal reducing agent, particularly a stannous reducing agent, preferably formed in the presence of a stabilizing ligand, which complex, when labelled with technetium-99m provides an excellent agent for imaging reticuloendothelial systems (RES), particularly the liver, spleen, and bone marrow; methods of making and using the same; a complex (physical or chemical) of technetium-99m with such microaggregates and methods of using such latter complex.
REFERENCES:
patent: 3720761 (1973-03-01), Hunter
patent: 3863004 (1975-01-01), Wolfangel
patent: 4071613 (1978-01-01), Hunter
Honda et al., J. of Nucl. Med., vol. 11, No. 10, 1970, pp. 580-585.
Bronstein Sewall P.
Neuner George W.
New England Nuclear Corporation
Nucker Christine M.
Padgett Benjamin R.
LandOfFree
Albumin microaggregates for radioactive scanning of reticuloendo does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Albumin microaggregates for radioactive scanning of reticuloendo, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Albumin microaggregates for radioactive scanning of reticuloendo will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-618565